Abstract:Cancer specific extracellular vesicles (EVs) are of significant clinical relevance, for instance programmed death ligand-1 (PD-L1) expressing EVs (PD-L1@EVs) have been shown to be ideal biomarker for non-invasive diagnosis of cancer and can predate the response of cancer patients to anti-PD-1/PD-L-1 immunotherapy. The development of sensitive and straightforward methods for detecting PD-L1@EVs can be a vital tool for non-invasive diagnosis of cancer. Most of the contemporary methods for EVs detection have limitations such as involvement of long and EV's loss prone isolation methods prior to detection or they have employed expensive antibodies and instruments to accomplish detection. Therefore, we designed an ultracentrifugation-free and antibody-free sensing assay for PD-L1@EV by integrating Titanium oxide (TiO2) coated magnetic beads (Fe3O4@TiO2) rapid capturing of EVs from undiluted serum with aptamers specificity and chemiluminescence (CL) sensitivity. To accomplish this we used Fe3O4@TiO2 beads to rapidly capture EVs from the undiluted patient serum and added biotin labelled PD-L1 aptamer to specifically recognize PD-L1@EVs. Later, added streptavidin-modified Alkaline phosphates (ALP) taking advantage of biotin-streptavidin strong binding. Addition of CDP-star, a chemiluminescent substrate of ALP, initiates the chemiluminiscense that was recorded using spectrophotometer. The sensing assay showed high sensitivity with limit of detection (LOD) as low as 2.584×105 EVs/mL and a wider linear correlation of CL intensity (a.u.) with the concentration of PD-L1@EVs from 105 to 108 EVs/mL. To examine the clinical utility of sensing assay we used undiluted serum samples from lung cancer patients and healthy individuals and successfully discern between healthy individuals and lung cancer patients. We are optimistic that the sensing assay can ameliorate our ability to be able to diagnose lung cancer non-invasively and can be helpful to predate the patient's response to anti-PD-1/PD-L1 immunotherapy.

Electrostimulus-associated PD-L1 Expression on Cell Membrane Revealed by Immune SERS Nanoprobes.

Development of a Sandwich ELISA for Evaluating Soluble PD-L1 (CD274) in Human Sera of Different Ages As Well As Supernatants of PD-L1+ Cell Lines

Unveiling cell metabolic bioprocess of programmed cell death ligand 1 (PD-L1) expression through nutrients-driven cancer immunomarker progression using SERS technique

An electrochemical biosensor for the assessment of tumor immunotherapy based on the detection of immune checkpoint protein programmed death ligand-1

Imaging of PD-L1 in single cancer cells by SERS-based hyperspectral analysis

Trace Analysis of Multiple Tumor Exosomal PD‐L1 Based on SERS Immunoassay Platform

Revealing Drug Treatment Effect from the SERS Profiles of Cell Membrane Biomolecules by a Silver Nanoparticle-Based Magnetic Plasmonic Probe

Label-Free Single-Particle Surface-Enhanced Raman Spectroscopy Detection of Phosphatidylserine Externalization on Cell Membranes with Multifunctional Micron-Nano Composite Probes

Programmable DNA Circuit-Facilitated Determination of Circulating Extracellular Vesicle PD-L1 for Lung Cancer Diagnosis and Immunotherapy Response Prediction.

Label-free and Specific Detection of Soluble Programmed Death Ligand-1 Using a Localized Surface Plasmon Resonance Biosensor Based on Excessively Tilted Fiber Gratings.

Localization of PD-L1 on single cancer cells by iSERS microscopy with Au/Au core/satellite nanoparticles

The Second Near-Infrared Window Quantum Dot-Based Fluorescence Anisotropy Probes for Separation-Free, Sensitive and Rapid Detection of Small Extracellular Vesicle PD-L1 in Plasma Samples

A digital microfluidic device integrated with electrochemical sensor and 3D matrix for detecting soluble PD-L1

An Immunoassay Method Based on Chemiluminescence and Magnetic Nanoparticles for Detection of Soluble Programmed Death 1 in Cancer Patients' Serum

Electrostimulus-triggered Reactive Oxygen Species Level in Organelles Revealed by Organelle-Targeting SERS Nanoprobes

Integrated microfluidic system for isolating exosome and analyzing protein marker PD-L1

An Electrochemical Biosensor for PD-L1 Positive Exosomes Based on Ultra-Thin Two-Dimensional Covalent Organic Framework Nanosheets Coupled with CRISPR-Cas12a Mediated Signal Amplification

Aptamer-Assisted Traceless Isolation of PD-L1-Positive Small Extracellular Vesicles for Dissecting Their Subpopulation Signature and Function

Upconversion nanoparticle-based fluorescence resonance energy transfer sensing of programmed death ligand 1 using sandwich epitope-imprinted polymers

Rapid Capturing and Chemiluminescent Sensing of Programmed Death Ligand-1 Expressing Extracellular Vesicles

Comprehensive Detection of PD-L1 Protein and mRNA in Tumor Cells and Extracellular Vesicles through a Real-Time qPCR Assay